214 related articles for article (PubMed ID: 27855499)
1. Synthesis and characterization of Fe
Atila Dinçer C; Yildiz N; Karakeçili A; Aydoğan N; Çalimli A
Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1408-1414. PubMed ID: 27855499
[TBL] [Abstract][Full Text] [Related]
2. Green Synthesized Montmorillonite/Carrageenan/Fe
Yew YP; Shameli K; Mohamad SE; Lee KX; Teow SY
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32659939
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
4. PLGA-based microparticles loaded with bacterial-synthesized prodigiosin for anticancer drug release: Effects of particle size on drug release kinetics and cell viability.
Obayemi JD; Danyuo Y; Dozie-Nwachukwu S; Odusanya OS; Anuku N; Malatesta K; Yu W; Uhrich KE; Soboyejo WO
Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():51-65. PubMed ID: 27207038
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.
Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L
Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936
[TBL] [Abstract][Full Text] [Related]
6. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
Ray S; Ghosh Ray S; Mandal S
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
[TBL] [Abstract][Full Text] [Related]
7. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of Cross-linked Poly (N-isopropylacrylamide) Magnetic Nano Composite for Application in the Controlled Release of Doxorubicin.
Kaamyabi S; Badrian A; Akbarzadeh A
Pharm Nanotechnol; 2017; 5(1):67-75. PubMed ID: 28948911
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization and in vitro anticancer activity of paclitaxel conjugated magnetic nanoparticles.
Tarantash M; Nosrati H; Kheiri Manjili H; Baradar Khoshfetrat A
Drug Dev Ind Pharm; 2018 Nov; 44(11):1895-1903. PubMed ID: 30073853
[TBL] [Abstract][Full Text] [Related]
10. PLGA/SBA-15 mesoporous silica composite microparticles loaded with paclitaxel for local chemotherapy.
Nanaki S; Siafaka PI; Zachariadou D; Nerantzaki M; Giliopoulos DJ; Triantafyllidis KS; Kostoglou M; Nikolakaki E; Bikiaris DN
Eur J Pharm Sci; 2017 Mar; 99():32-44. PubMed ID: 27939620
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of MnO
Gupta VK; Fakhri A; Agarwal S; Ahmadi E; Nejad PA
J Photochem Photobiol B; 2017 Sep; 174():235-242. PubMed ID: 28802174
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA-PEG6000 copolymers in treatment of lung cancer.
Nejati-Koshki K; Mesgari M; Ebrahimi E; Abbasalizadeh F; Fekri Aval S; Khandaghi AA; Abasi M; Akbarzadeh A
J Microencapsul; 2014; 31(8):815-23. PubMed ID: 25090589
[TBL] [Abstract][Full Text] [Related]
14. Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis.
Zhou J; Guo D; Zhang Y; Wu W; Ran H; Wang Z
ACS Appl Mater Interfaces; 2014 Apr; 6(8):5566-76. PubMed ID: 24693875
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin loaded magnetic Fe3O4/carboxymethylchitosan nanoparticles as tumor-targeted drug delivery system: Synthesis and in vitro characterization.
Li G; Cao L; Zhou Z; Chen Z; Huang Y; Zhao Y
Colloids Surf B Biointerfaces; 2015 Apr; 128():379-388. PubMed ID: 25779605
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical characteristics of Fe3O4 magnetic nanocomposites based on Poly(N-isopropylacrylamide) for anti-cancer drug delivery.
Davaran S; Alimirzalu S; Nejati-Koshki K; Nasrabadi HT; Akbarzadeh A; Khandaghi AA; Abbasian M; Alimohammadi S
Asian Pac J Cancer Prev; 2014; 15(1):49-54. PubMed ID: 24528080
[TBL] [Abstract][Full Text] [Related]
17. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
[TBL] [Abstract][Full Text] [Related]
18. Development of facile drug delivery platform of ranibizumab fabricated PLGA-PEGylated magnetic nanoparticles for age-related macular degeneration therapy.
Yan J; Peng X; Cai Y; Cong W
J Photochem Photobiol B; 2018 Jun; 183():133-136. PubMed ID: 29704861
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, purification, and anticancer effect of magnetic Fe
Wang K; Hu H; Zhang Q; Zhang Y; Shi C
J Microencapsul; 2019 Jun; 36(4):356-370. PubMed ID: 31190597
[TBL] [Abstract][Full Text] [Related]
20. Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells.
Le Broc-Ryckewaert D; Carpentier R; Lipka E; Daher S; Vaccher C; Betbeder D; Furman C
Int J Pharm; 2013 Oct; 454(2):712-9. PubMed ID: 23707251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
